Glofitamab,Obinutuzumab,Tocilizumab
roche
['glofitamab', 'lymsm']
glofitamab responses quite durable for responders, but cr rate is &lt;40% overall. another tool to add to the armamentarium? #ash22 #lymsm
Asst. Professor of Medicine, Hematology/Oncology at @PennStHershey, clinical: myeloma #MMSM, lymphoma #lymsm, @Penn alum, @PennStHershey alum. Tweets my own.